Cipher Digital, Micron, and Broadcom all look poised to be big winners as Alphabet continues to boost its capex budget.

Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer’s top healthcare stocks even though the shares have been lackluster. They are up by a modest 27% year-to-date, with most of the gains ...

International Business Machines Corporation (NYSE:IBM) is another stock that Jim Cramer has continued to stick by, even though the shares have struggled. For more than a year, the CNBC TV host has ...

Novo Nordisk A/S (NYSE:NVO) was at the center of media coverage as it sued rival weight loss drug manufacturer Eli Lilly on Tuesday. The firm claimed that Lilly had run misleading advertisements about ...

Attackers reportedly drained $9.7M from Triple-A hot wallets across four chains and bridged the funds to Ethereum.

Although some people see retirement as a time to stop working, you may continue to hold down a job as a retiree for extra money, boredom relief, or a combination of both. But earning a paycheck could ...

With shares falling 24% from their all-time record, it's time to take a closer look at this Latin American fintech enterprise ...

U.S. youth delegation came to Dali of Yunnan Province. By examining how Dali's rich history intersects with modern development, the delegates explored new pathways for rural development.

Corcept Therapeutics (CORT) has attracted fresh attention after a sharp improvement in its earnings outlook, with full year ...

Vizsla Silver (TSX:VZLA) is back in focus after reporting full year results to April 30, 2026, with a net loss of US$38.69 ...

C3.ai (AI) is back in focus after a federal court dismissed a securities class action lawsuit against the company, and recent ...

MannKind Corporation has now received U.S. FDA approval for Furoscix ReadyFlow, an at-home autoinjector delivering an IV‑equivalent 80 mg/mL furosemide dose in under 10 seconds to treat edema in ...